NRF2 is overexpressed in ovarian epithelial carcinoma and is regulated by gonadotrophin and sex-steroid hormones

Oncology Reports

Volumn 27, Issue 6, 2012, Pages 1918-1924

  Liao, Hong ^a   Zhou, Qian ^a   Zhang, Zhenbo ^b   Wang, Qianqian ^b   Sun, Yunyan ^b   Yi, Xiaofang ^c   Feng, Youji ^b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Gonadotrophin; Nuclear factor erythroid 2; Ovarian epithelial carcinoma; Reactive oxygen species; Sex steroid hormones

Indexed keywords

ESTROGEN; GONADOTROPIN; REACTIVE OXYGEN METABOLITE; SEX HORMONE; TRANSCRIPTION FACTOR NRF2;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CYSTADENOCARCINOMA; CYSTADENOMA; DISEASE ASSOCIATION; ENDOMETRIOID CARCINOMA; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HORMONAL CARCINOGENESIS; HORMONAL REGULATION; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MOLECULAR MODEL; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADULT; AGED; CELL LINE, TUMOR; CYSTADENOMA; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADAL STEROID HORMONES; GONADOTROPINS; HUMANS; LUTEINIZING HORMONE; MEDROXYPROGESTERONE; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; NF-E2-RELATED FACTOR 2; OVARIAN NEOPLASMS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84860708221     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1700     Document Type: Article

References (23)

1. Wang J, Zhang M, Zhang L, et al: Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival. J Surg Res 164: 99-105, 2010.
2. Jiang T, Chen N, Zhao F, et al: High levels of Nrf2 determine chemoresistance in type II endometrial cancer. Cancer Res 70: 5486-5496, 2010.
3. Chen N, Yi X, Abushahin N, et al: Nrf2 expression in endometrial serous carcinomas and its precancers. Int J Clin Exp Pathol 4: 85-96, 2010.
4. Wang XJ, Sun Z, Villeneuve NF, et al: Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29: 1235-1243, 2008. (Pubitemid 351958704)
5. Akhdar H, Loyer P, Rauch C, Corlu A, Guillouzo A and Morel F: Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells. Eur J Cancer 45: 2219-2227, 2009.
6. Yao Y, Brodie AM, Davidson NE, Kensler TW and Zhou Q: Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer. Breast Cancer Res Treat 124: 585-591, 2010.
7. Lister A, Nedjadi T, Kitteringham NR, et al: Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy. Mol Cancer 10: 37, 2011.
8. Fer ND, Shoemaker RH and Monks A: Adaphostin toxicity in a sensitive non-small cell lung cancer model is mediated through Nrf2 signaling and heme oxygenase 1. J Exp Clin Cancer Res 29: 91, 2010.
9. Beyer TA, Auf dem Keller U, Braun S, Schafer M and Werner S: Roles and mechanisms of action of the Nrf2 transcription factor in skin morphogenesis, wound repair and skin cancer. Cell Death Differ 14: 1250-1254, 2007. (Pubitemid 46965255)
10. Shkolnik K, Tadmor A, Ben-Dor S, Nevo N, Galiani D and Dekel N: Reactive oxygen species are indispensable in ovulation. Proc Natl Acad Sci USA 108: 1462-1467, 2011.
11. Kim TH, Hur EG, Kang SJ, et al: NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α. Cancer Res 71: 2260-2275, 2011.
12. Bae YS, Kang SW, Seo MS, et al: Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272: 217-221, 1997. (Pubitemid 27021147)
13. Ohba M, Shibanuma M, Kuroki T and Nose K: Production of hydrogen peroxide by transforming growth factor-β1 and its involvement in induction of egr-1 in mouse osteoblastic cells. J Cell Biol 126: 1079-1088, 1994. (Pubitemid 24252152)
14. Sundaresan M, Yu ZX, Ferrans VJ, et al: Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem J 318: 379-382, 1996. (Pubitemid 26305933)
15. 2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
16. + signaling followed by phospholipase-A2 activation and potentiated by an adenosine derivative. Endocrinology 136: 116-123, 1995.
17. Li Y, Ganta S, Cheng C, Craig R, Ganta RR and Freeman LC: FSH stimulates ovarian cancer cell growth by action on growth factor variant receptor. Mol Cell Endocrinol 267: 26-37, 2007.
18. Zheng W, Lu JJ, Luo F, et al: Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone. Gynecol Oncol 76: 80-88, 2000. (Pubitemid 30048324)
19. Gan N, Sun X and Song L: Activation of Nrf2 by microcystin-LR provides advantages for liver cancer cell growth. Chem Res Toxicol 23: 1477-1484, 2010.
20. Homma S, Ishii Y, Morishima Y, et al: Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin Cancer Res 15: 3423-3432, 2009.
21. Wu AH and Pike MC: Dietary soy protein and hormonal status in females. Am J Clin Nutr 62: 151-153, 1995.
22. Harding M, Cowan S, Hole D, et al: Estrogen and progesterone receptors in ovarian cancer. Cancer 65: 486-491, 1990. (Pubitemid 20058365)
23. Okoh V, Deoraj A and Roy D: Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer. Biochim Biophys Acta 1815: 115-133, 2011.